TauroPharm GmbH
In 2000, TauroPharm GmbH was founded as a German company specialising in medical devices with antimicrobial efficacy. We have since developed a variety of innovative products and built an international network. As TauroLock solutions have been approved in current guidelines, we continue to expand our reach and explore new possibilities.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Globally (various continents)
- Year Founded:
- 2000
Our Mission
TauroPharm GmbH aims to make the application of vascular access devices (VAD) easier and safer. In particular, we are developing more effective ways to prevent catheter-associated complications – ranging from blood clottings to fatal infections. Throughout this process, improving the patient’s quality of life remains our top priority.
Our Products
We have created a diverse range of lock solutions suitable for implanted central-venous catheters (CVC) and port systems. These products contain several ingredients that ensure two effects at once:
- prevention of catheter-related infections
- prevention of catheter occlusion
As the number of antibiotic-resistant pathogens steadily increases, the need for our products has become more urgent in recent years. Today, TauroLock™ solutions are recommended in interdisciplinary guidelines on a national and international scale.
All products offered by TauroPharm GmbH have been tested and approved in independent studies.
Our Quality Standards
We aim to continuously refine and optimise our lock solutions with regard to their specific application. For that purpose, we seek feedback from patients with implanted access systems (e.g. catheters and ports) on a regular basis.
TauroPharm GmbH has thus become the sole supplier of a lock solution that contains urokinase and yields an antimicrobial effect. This product tackled a long-standing problem in the medical field: With TauroLockTM-U25.000, it is now possible to prevent catheter-related infections and occlusions by administering just one lock solution.
Our Sales Network
As a manufacturer, TauroPharm GmbH focuses on four key areas:
- product development
- production
- training
- quality management
In order to distribute our products, we collaborate with international partners who provide support and advice to customers in their respective countries. Our correspondents have been carefully selected and hold trust-based partnerships with healthcare professionals in various fields:
nephrology . oncology . gastroenterology . intensive and palliative medicine . home care
Beyond our existing partners, we continue to connect with new distributors and raise awareness for our cause.
Our Educational Programs
TauroPharm GmbH aspires to make treatments with CVC systems as secure and comfortable as possible. With this in mind, we offer special training sessions in Germany and all other countries where TauroLock™ products are sold and implemented. These programmes help distributors to familiarise themselves with our lock solutions and their application.